Yarrow Bioscience, Inc. (YARW)
17.00
-0.92
(-5.16%)
USD |
NASDAQ |
Nov 03, 14:23
Yarrow Bioscience Price to Book Value : 0.5151 for Nov. 3, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 02, 2026 | 0.5431 |
| October 30, 2026 | 0.6028 |
| October 29, 2026 | 0.6058 |
| October 28, 2026 | 0.5928 |
| October 27, 2026 | 0.6095 |
| October 26, 2026 | 0.6058 |
| October 23, 2026 | 0.5837 |
| October 22, 2026 | 0.5937 |
| October 21, 2026 | 0.611 |
| October 20, 2026 | 0.6122 |
| October 19, 2026 | 0.6052 |
| October 16, 2026 | 0.5546 |
| October 15, 2026 | 0.6058 |
| October 14, 2026 | 0.5725 |
| October 13, 2026 | 0.5634 |
| October 12, 2026 | 0.6004 |
| October 09, 2026 | 0.5971 |
| October 08, 2026 | 0.6019 |
| October 07, 2026 | 0.5687 |
| October 06, 2026 | 0.5674 |
| October 05, 2026 | 0.6149 |
| October 02, 2026 | 0.6746 |
| October 01, 2026 | 0.7149 |
| September 30, 2026 | 0.6822 |
| September 29, 2026 | 0.7328 |
| Date | Value |
|---|---|
| September 28, 2026 | 0.727 |
| September 25, 2026 | 0.7737 |
| September 24, 2026 | 0.7897 |
| September 23, 2026 | 0.8445 |
| September 22, 2026 | 0.8688 |
| September 21, 2026 | 0.8573 |
| September 18, 2026 | 0.8872 |
| September 17, 2026 | 0.9263 |
| September 16, 2026 | 0.7858 |
| September 15, 2026 | 0.7724 |
| September 14, 2026 | 0.7955 |
| September 11, 2026 | 0.8182 |
| September 10, 2026 | 0.8615 |
| September 09, 2026 | 0.8818 |
| September 08, 2026 | 0.8876 |
| September 04, 2026 | 0.9151 |
| September 03, 2026 | 0.8739 |
| September 02, 2026 | 0.9082 |
| September 01, 2026 | 0.9384 |
| August 31, 2026 | 0.9984 |
| August 28, 2026 | 1.121 |
| August 27, 2026 | 1.151 |
| August 26, 2026 | 1.201 |
| August 25, 2026 | 1.189 |
| August 24, 2026 | 1.196 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Cypherpunk Technologies, Inc. | 1.996 |
| Cue Biopharma, Inc. | 44.66 |
| Faeth Therapeutics, Inc. | 2.949 |
| Indaptus Therapeutics, Inc. | 38.55 |
| Pyxis Oncology, Inc. | 9.122 |
Price to Book Value Related Metrics
| PS Ratio | 28.54 |
| Price | 17.00 |
| Earnings Yield | -137.9% |
| Market Cap | 11.36M |